Questions discussed in this category
Will you try the sublingual formulation in a patient who has failed the oral formulation, or vice versa?
What tools do you track to assess progress toward these goals?
What are common drug interactions/things to be aware of?
1936024904271162725224197
Papers discussed in this category
The Lancet. Rheumatology, 2023 Dec 05
Pain reports, 2023 Jun 15
The Lancet. Rheumatology, 2023 Dec 05
Frontiers in medicine, 2023 Apr 25
Arthritis and rheumatism, 1994-01
Pain medicine (Malden, Mass.), 2025 Jul 08
Arthritis care & research, 2023 Jul 04
Annals of medicine, 2011 Jul 19